The tools in the kit. Plain-language. No hype.
Body Protective Compound. Derived from a protein found in gastric juice. Known for accelerating recovery of muscle, tendon, ligament, and gut tissue.
Common use: Soft tissue injuries, chronic joint pain, gut inflammation, post-surgical recovery.
Typically injected subcutaneously near the injury site, though systemic use is also common.
Thymosin Beta-4 fragment. Systemic healing agent that promotes actin regulation and cellular migration to injury sites.
Common use: Widespread soft tissue recovery, often stacked with BPC-157 for injury protocols.
Weekly subQ injection. Most patients run it in cycles.
Growth Hormone Releasing Hormone (GHRH) analog. Stimulates your own pituitary to release GH in a natural pulsatile pattern.
Common use: Improved sleep, recovery, body composition, skin quality. Not a "steroid" — it's your own GH.
Typically paired with Ipamorelin.
GH secretagogue. Selective — doesn't meaningfully raise cortisol or prolactin like older peptides.
Common use: Stacked with CJC-1295 for synergistic GH release. Sleep, recovery, fat loss.
SubQ injection, typically before bed.
Melanocortin receptor agonist. Works centrally on the nervous system rather than vascularly.
Common use: Libido and sexual function in men and women. Alternative for those who don't tolerate or can't use PDE5 inhibitors.
SubQ injection taken on-demand.
GHRH 1-29 fragment. Older cousin of CJC-1295. Shorter half-life, more frequent dosing.
Common use: General GH support, anti-aging protocols, recovery.
Nightly subQ injection.
Modified fragment of GH (176-191). Targets fat metabolism without the broader effects of full-length GH.
Common use: Adjunct for body composition goals. Often combined with other protocols.
Daily subQ injection during active cycles.
GLP-1 receptor agonist. FDA-approved class. Significant weight loss and metabolic improvements.
Common use: Medically supervised weight management, metabolic health, pre-diabetes.
Weekly subQ injection. Requires ongoing monitoring.